Delivery Order SPE2DB24D2101-SPE2DB25FKJAP

Award Date 3/28/25
Potential Completion Date 3/31/25
Potential Value $16K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of JARDIANCE 25 MG TABLET 90S, a pharmaceutical product, with a ceiling value of $16,647.60 and a period of performance through March 19, 2025. The contract is a firm fixed-price Indefinite Delivery Contract (IDC) and does not have a set-aside designation, indicating open competition....
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of JARDIANCE 25 MG TABLET 90S, a pharmaceutical product, with a firm fixed price and a ceiling value of $16,969.32. The contract has an ultimate completion date of May 20, 2025. This contract is not set aside and is an open competition. Amerisourcebergen Drug Corp holds a significant...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of JARDIANCE 25 MG TABLET 90S, a pharmaceutical product, with a ceiling value of $49,878.88 and an ultimate completion date of March 3, 2025. The contract is a Firm Fixed Price type and is not designated as a set-aside. AmerisourceBergen holds a significant Indefinite Delivery...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of JARDIANCE 25 MG TABLET 90S, a pharmaceutical product. The contract has a ceiling value of $22,889.67 and an ultimate completion date of January 9, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of JARDIANCE 25 MG TABLET 90S, a pharmaceutical product, with a ceiling value of $10,652.53. The contract has an ultimate completion date of April 7, 2025 and is a firm fixed-price contract. There is no set-aside designation mentioned. AmerisourceBergen Drug Corp holds a significant...
This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $24,553.77 and a period of performance through April 9, 2025. It is for the supply of the pharmaceutical product JARDIANCE 25 MG TABLET 90S. The contract is a Firm Fixed Price arrangement and does not have a set-aside designation, indicating open competition. AmerisourceBergen...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of JARDIANCE 10 MG TABLET 90S, a pharmaceutical product, with a ceiling value of $15,808.06 and a period of performance through February 14, 2024. The contract is a firm fixed-price delivery order and was not designated with a set-aside requirement, indicating open competition....
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of JARDIANCE 25 MG TABLET 90S, a pharmaceutical product, with a ceiling value of $6,333.77 and a period of performance through May 22, 2025. The contract is a firm fixed-price, non-set-aside award, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of JARDIANCE 25 MG TABLET 90S, a pharmaceutical product, with a ceiling value of $13,899.39 and a period of performance through February 7, 2024. The contract is a firm fixed price delivery order type and was not set aside for any specific business category. AmerisourceBergen...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $10,528.61, is for the supply of JARDIANCE 25 MG TABLET 90S, a cardiovascular medication. The contract has a period of performance through October 30, 2024 and is a firm fixed-price contract. This order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop...
  • SPE2DB24D2101
    Indefinite Delivery Contract
  • SPE2DB24D2101-SPE2DB25FKJAP
    Delivery Order

This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of JARDIANCE 25 MG TABLET 90S, a pharmaceutical product, with a ceiling value of $15,895.84. The contract is a firm fixed-price delivery order that runs through March 31, 2025. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.

Generated 6/27/25, 11:59 AM